At A Glance

Name: Daniel Liebler

Age: 44

Position: Beginning of May 2003: Professor of biochemistry and director of proteomics, Vanderbilt University Medical Center

Currently: Professor, department of pharmacology and toxicology, University of Arizona, since 1987; Director, Southwest Environmental Health Sciences Center, since 1999

Prior Experience: Postdoc, Oregon State University, 1984-87. Worked with Donald Reed on cellular protection mechanisms and antioxidants.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.